Showing results (1321-1330 of 1,403) with videos related to

Sort By:
Pageof 141
Vox Sanguinis|April 14, 2020
Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectorsMark H Yazer, Beth Shaz, Jansen N Seheult, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 19, 2015
Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitalsJ M Fitzpatrick, J S Biswas, J D Edgeworth, et al.
Molecular Cancer Therapeutics|July 26, 2013
Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancersErik A Bey, Kathryn E Reinicke, Melissa C Srougi, et al.
International Journal of Cancer|April 28, 2020
Phase III randomized, double-blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum-containing regimen (RADPAC)Sylvie Lorenzen, Jorge Riera Knorrenschild, Claudia Pauligk, et al.
The Journal of Clinical Investigation|October 22, 2024
Combined HDAC8 and checkpoint kinase inhibition induces tumor-selective synthetic lethality in preclinical modelsTing-Yu Chang, Yan Yan, Zih-Yao Yu, et al.
Plos One|December 24, 2011
Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humansHenrik Zetterberg, Erik Mörtberg, Linan Song, et al.
Journal of Medicinal Chemistry|January 15, 2019
Tricyclic Indazoles-A Novel Class of Selective Estrogen Receptor Degrader AntagonistsJames S Scott, Andrew Bailey, David Buttar, et al.
The Journal of Clinical Investigation|June 28, 2022
Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expressionEmilia A Korhonen, Aino Murtomäki, Sawan Kumar Jha, et al.
Infectious Diseases and Therapy|September 5, 2020
Strategic Anti-SARS-CoV-2 Serology Testing in a Low Prevalence Setting: The COVID-19 Contact (CoCo) Study in Healthcare ProfessionalsGeorg M N Behrens, Anne Cossmann, Metodi V Stankov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2019
A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid LeukemiaAnjali S Advani, Brenda Cooper, Valeria Visconte, et al.
Pageof 141